[go: up one dir, main page]

DE60107248D1 - Neues verfahren zur herstellung von pyrazolopyrimidonen - Google Patents

Neues verfahren zur herstellung von pyrazolopyrimidonen

Info

Publication number
DE60107248D1
DE60107248D1 DE60107248T DE60107248T DE60107248D1 DE 60107248 D1 DE60107248 D1 DE 60107248D1 DE 60107248 T DE60107248 T DE 60107248T DE 60107248 T DE60107248 T DE 60107248T DE 60107248 D1 DE60107248 D1 DE 60107248D1
Authority
DE
Germany
Prior art keywords
pyrazolopyrimidones
production
new method
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60107248T
Other languages
English (en)
Other versions
DE60107248T2 (de
Inventor
Edward Bunnage
Charles Levett
Murray Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60107248(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015462A external-priority patent/GB0015462D0/en
Priority claimed from GB0105878A external-priority patent/GB0105878D0/en
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of DE60107248D1 publication Critical patent/DE60107248D1/de
Application granted granted Critical
Publication of DE60107248T2 publication Critical patent/DE60107248T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60107248T 2000-06-22 2001-06-07 Neues verfahren zur herstellung von pyrazolopyrimidonen Expired - Fee Related DE60107248T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0015462A GB0015462D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0015462 2000-06-22
GB0105878 2001-03-09
GB0105878A GB0105878D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazoloprimidinones
PCT/IB2001/001038 WO2001098303A1 (en) 2000-06-22 2001-06-07 Novel process for the preparation of pyrazolopyrimidinones

Publications (2)

Publication Number Publication Date
DE60107248D1 true DE60107248D1 (de) 2004-12-23
DE60107248T2 DE60107248T2 (de) 2005-12-01

Family

ID=26244537

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60107248T Expired - Fee Related DE60107248T2 (de) 2000-06-22 2001-06-07 Neues verfahren zur herstellung von pyrazolopyrimidonen

Country Status (25)

Country Link
EP (1) EP1296983B1 (de)
JP (1) JP2004501154A (de)
KR (1) KR100525699B1 (de)
AP (1) AP2001002195A0 (de)
AR (1) AR028729A1 (de)
AT (1) ATE282619T1 (de)
AU (2) AU6259201A (de)
BR (1) BR0111864A (de)
CA (1) CA2411957C (de)
CZ (1) CZ20024130A3 (de)
DE (1) DE60107248T2 (de)
ES (1) ES2231498T3 (de)
GT (2) GT200100113AA (de)
HU (1) HUP0301207A3 (de)
IL (1) IL152983A0 (de)
MX (1) MXPA02012887A (de)
MY (1) MY127737A (de)
PA (1) PA8520001A1 (de)
PE (1) PE20020091A1 (de)
PL (1) PL360299A1 (de)
PT (1) PT1296983E (de)
SV (1) SV2002000502A (de)
TN (1) TNSN01092A1 (de)
WO (1) WO2001098303A1 (de)
YU (1) YU84702A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
AU5995699A (en) * 1998-10-23 2000-05-15 Bunnage, Mark Edward Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction

Also Published As

Publication number Publication date
HK1079198A1 (en) 2006-03-31
KR100525699B1 (ko) 2005-11-03
HUP0301207A2 (hu) 2003-08-28
AU2001262592B2 (en) 2006-07-06
SV2002000502A (es) 2002-07-03
WO2001098303A1 (en) 2001-12-27
BR0111864A (pt) 2003-07-01
PT1296983E (pt) 2005-02-28
ES2231498T3 (es) 2005-05-16
YU84702A (sh) 2005-09-19
CA2411957C (en) 2007-09-18
KR20030017556A (ko) 2003-03-03
HUP0301207A3 (en) 2006-02-28
MY127737A (en) 2006-12-29
GT200100113A (es) 2002-06-04
DE60107248T2 (de) 2005-12-01
AP2001002195A0 (en) 2002-12-21
MXPA02012887A (es) 2003-05-14
AU6259201A (en) 2002-01-02
EP1296983B1 (de) 2004-11-17
PA8520001A1 (es) 2003-09-05
PL360299A1 (en) 2004-09-06
CZ20024130A3 (cs) 2004-01-14
PE20020091A1 (es) 2002-02-21
CA2411957A1 (en) 2001-12-27
JP2004501154A (ja) 2004-01-15
IL152983A0 (en) 2003-06-24
EP1296983A1 (de) 2003-04-02
TNSN01092A1 (fr) 2005-11-10
AR028729A1 (es) 2003-05-21
ATE282619T1 (de) 2004-12-15
GT200100113AA (es) 2006-04-10

Similar Documents

Publication Publication Date Title
AT7110U3 (de) Verfahren zur herstellung von amlodipinmaleat
DE60224643D1 (de) Verfahren zur herstellung von reifen
DE60206031D1 (de) Verfahren zur herstellung von seltenerdlegierungs sinterformteilen
DE60225539D1 (de) Verfahren zur kontinuierlichen herstellung von polyarylensulfid
DE60226766D1 (de) Verfahren zur herstellung von phenolischen novolaken
DE60324813D1 (de) Verfahren zur Herstellung von Wellenleitern
DE50114795D1 (de) Verfahren zur herstellung von polyisobutenylphenolen
DE60026607D1 (de) Verfahren zur herstellung von perfluoroalkadienen
DE60204334D1 (de) Verfahren zur herstellung von repaglinide
DE60015189D1 (de) Verfahren zur Herstellung von SiON-Wellenleiter
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE266004T1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4- methylpyridin
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
ATA218299A (de) Verfahren zur herstellung von oxindolen
DE60131562D1 (de) Verfahren zur herstellung von benztriazolen
EP1320367A4 (de) Verfahren zur herstellung von dinapsolin
DE60141311D1 (de) Verfahren zur Herstellung von Diaphragmen
DE60039688D1 (de) Verfahren zur herstellung von uhrarmbandteilen
DE60113157D1 (de) Verbessertes verfahren zur herstellung von simvastatin
DE60105991D1 (de) Verfahren zur herstellung von 6-aminocapronamid
DE60012337D1 (de) Verfahren zur herstellung von fluorcarbonsäureanyhydriden
DE60109786D1 (de) Verfahren zur herstellung von hydroxylactonen
DE50008921D1 (de) Verfahren zur herstellung von blockweichschaumpolyolen
ATE327995T1 (de) Verfahren zur herstellung von camptothectin
ATE325810T1 (de) Verfahren zur herstellung von acetylamidiniophenylalanyl-cyclohexylglycyl- pyridylalaninamiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee